• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

年轻结肠癌患者的淋巴结检出率和淋巴结转移情况:基于年龄的不同,癌症存活率是否存在差异?

Node yield and node involvement in young colon cancer patients: is there a difference in cancer survival based on age?

机构信息

Department of Public Health Sciences, The Pennsylvania State University, College of Medicine, Hershey, PA 17033, USA.

出版信息

J Gastrointest Surg. 2010 Sep;14(9):1355-61. doi: 10.1007/s11605-010-1275-y. Epub 2010 Jun 29.

DOI:10.1007/s11605-010-1275-y
PMID:20585992
Abstract

BACKGROUND

The effect on cancer-specific survival (CSS) from the number of resected nodes (node yield) and the number of nodes involved with colon cancer has not been studied with respect to age.

PATIENT AND METHODS

Data from 1992 to 2006 from the Surveillance, Epidemiology and End Results (SEER) registry were analyzed for colon cancer patients undergoing curative resection, comparing younger (< 40; n = 2,642) and older (> or = 40; n = 138,769) patients.

RESULTS

The mean number of positive nodes and mean node yield was higher for the younger group. Younger patients were more likely to have metastatic disease and to have a nodal yield of > or = 12 nodes, and were less likely to have node-negative colon cancers (all p < 0.0001). Younger age was associated with a lower risk of death from colon cancer (HR = 0.65; p < 0.0001). No CSS effect was noted with the interaction of age with either node yield or node involvement. Node yield < 12 created a higher risk of cancer-specific death (HR = 1.22; p < 0.0001) regardless of stage. KM plots by stage demonstrated a CSS advantage (p < 0.0001) for younger patients.

CONCLUSIONS

Younger patients with colon cancers do not have a worse CSS simply because of their young age, so long as proper oncologic surgical principles are adhered to.

摘要

背景

关于年龄因素对切除淋巴结数量(淋巴结检出数)和结肠癌淋巴结受累数量对癌症特异性生存(CSS)的影响,尚未有研究报道。

患者和方法

分析了 1992 年至 2006 年监测、流行病学和最终结果(SEER)登记处的结肠癌患者数据,这些患者接受根治性切除术,比较了年龄较轻(<40 岁;n=2642)和年龄较大(≥40 岁;n=138769)的患者。

结果

年轻组的阳性淋巴结数量和平均淋巴结检出数更高。年轻患者更有可能患有转移性疾病和淋巴结检出数≥12 个,并且更不可能患有淋巴结阴性结肠癌(均p<0.0001)。年轻与结肠癌死亡风险降低相关(HR=0.65;p<0.0001)。年龄与淋巴结检出数或淋巴结受累之间无交互作用,CSS 无影响。无论分期如何,淋巴结检出数<12 均会增加癌症特异性死亡的风险(HR=1.22;p<0.0001)。按分期绘制的 KM 图显示年轻患者具有 CSS 优势(p<0.0001)。

结论

只要遵循适当的肿瘤外科原则,年轻结肠癌患者 CSS 较差并不是因为他们的年轻,而是因为其他原因。

相似文献

1
Node yield and node involvement in young colon cancer patients: is there a difference in cancer survival based on age?年轻结肠癌患者的淋巴结检出率和淋巴结转移情况:基于年龄的不同,癌症存活率是否存在差异?
J Gastrointest Surg. 2010 Sep;14(9):1355-61. doi: 10.1007/s11605-010-1275-y. Epub 2010 Jun 29.
2
Lymph node involvement in colon cancer patients decreases with age; a population based analysis.结肠癌患者的淋巴结受累情况随年龄增长而减少:一项基于人群的分析。
Eur J Surg Oncol. 2014 Nov;40(11):1474-80. doi: 10.1016/j.ejso.2014.06.002. Epub 2014 Jul 3.
3
Trends in lymph node excision and impact of positive lymph node ratio in patients with colectomy for primary colon adenocarcinoma: Population based study 1988 to 2011.1988年至2011年原发性结肠腺癌患者结肠切除术时淋巴结切除趋势及阳性淋巴结比例的影响:基于人群的研究
Surg Oncol. 2016 Sep;25(3):158-63. doi: 10.1016/j.suronc.2016.05.013. Epub 2016 May 20.
4
Increasing the number of lymph nodes examined after colectomy does not improve colon cancer staging.结肠切除术后增加检查的淋巴结数量并不会改善结肠癌分期。
J Am Coll Surg. 2014 May;218(5):1004-11. doi: 10.1016/j.jamcollsurg.2014.01.039. Epub 2014 Jan 24.
5
Nodal status, number of lymph nodes examined, and lymph node ratio: what defines prognosis after resection of colon adenocarcinoma?淋巴结状态、检查的淋巴结数量和淋巴结比率:切除结肠癌后,哪些因素决定预后?
J Am Coll Surg. 2013 Dec;217(6):1090-100. doi: 10.1016/j.jamcollsurg.2013.07.404. Epub 2013 Sep 14.
6
Association Between Very Small Tumor Size and Increased Cancer-Specific Mortality in Node-Positive Colon Cancer.微小肿瘤大小与淋巴结阳性结肠癌患者癌症特异性死亡率增加之间的关联。
Dis Colon Rectum. 2016 Mar;59(3):187-93. doi: 10.1097/DCR.0000000000000532.
7
Alterations of lymph nodes evaluation after colon cancer resection: patient and tumor heterogeneity should be taken into consideration.结肠癌切除术后淋巴结评估的改变:应考虑患者和肿瘤的异质性。
Oncotarget. 2016 Sep 20;7(38):62664-62675. doi: 10.18632/oncotarget.11633.
8
Lymph node yield and tumour subsite are associated with survival in stage I-III colon cancer: results from a national cohort study.淋巴结检出数和肿瘤亚部位与 I-III 期结肠癌的生存相关:来自全国队列研究的结果。
World J Surg Oncol. 2019 Apr 2;17(1):62. doi: 10.1186/s12957-019-1604-x.
9
Prognostic value of total number of lymph nodes retrieved differs between left-sided colon cancer and right-sided colon cancer in stage III patients with colon cancer.在 III 期结肠癌患者中,左半结肠癌和右半结肠癌的淋巴结总数的预后价值不同。
BMC Cancer. 2018 May 11;18(1):558. doi: 10.1186/s12885-018-4431-5.
10
Adequate lymph node evaluation in the elderly is associated with improved survival in patients with stage I-III colon cancer: A validation study using the National Cancer Data Base.老年患者充分的淋巴结评估与I-III期结肠癌患者生存率提高相关:一项使用国家癌症数据库的验证研究
Eur J Surg Oncol. 2018 Jan;44(1):148-156. doi: 10.1016/j.ejso.2017.11.005. Epub 2017 Nov 23.

引用本文的文献

1
Predicting lymph node metastasis in colorectal cancer patients: development and validation of a column chart model.预测结直肠癌患者的淋巴结转移:列线图模型的建立与验证。
Updates Surg. 2024 Aug;76(4):1301-1310. doi: 10.1007/s13304-024-01884-6. Epub 2024 Jul 2.
2
Comparing surgical and endoscopic resection approaches for colorectal neuroendocrine tumors within the diameter range of 10-20mm: an inverse probability weighting analysis based on the SEER database.比较直径范围在 10-20mm 的结直肠神经内分泌肿瘤的手术和内镜切除方法:基于 SEER 数据库的逆概率加权分析。
Front Endocrinol (Lausanne). 2024 Mar 27;15:1378968. doi: 10.3389/fendo.2024.1378968. eCollection 2024.
3

本文引用的文献

1
Young age influences treatment but not outcome of colon cancer.年轻影响结肠癌的治疗,但不影响其预后。
Ann Surg Oncol. 2007 Oct;14(10):2759-65. doi: 10.1245/s10434-007-9465-x. Epub 2007 Jun 26.
2
Lymph node evaluation and survival after curative resection of colon cancer: systematic review.结肠癌根治性切除术后的淋巴结评估与生存:系统评价
J Natl Cancer Inst. 2007 Mar 21;99(6):433-41. doi: 10.1093/jnci/djk092.
3
Lymph node evaluation in colorectal cancer patients: a population-based study.结直肠癌患者的淋巴结评估:一项基于人群的研究。
A Preoperative Scoring System to Predict the Risk of Inadequate Lymph Node Count in Rectal Cancer.
一种预测直肠癌淋巴结计数不足风险的术前评分系统。
Front Oncol. 2022 Jul 8;12:938996. doi: 10.3389/fonc.2022.938996. eCollection 2022.
4
Presentation and survival among patients with colorectal cancer before the age of screening: a systematic review and meta-analysis.筛查前结直肠癌患者的临床表现和生存情况:系统评价和荟萃分析。
Can J Surg. 2021 Feb 18;64(1):E91-E100. doi: 10.1503/cjs.013019.
5
Identification of Risk Factors Associated With Stage III Disease in Nonmetastatic Colon Cancer: Results From a Prospective National Cohort Study.非转移性结肠癌Ⅲ期疾病相关危险因素的识别:一项前瞻性全国队列研究的结果
Ann Coloproctol. 2020 Oct;36(5):316-322. doi: 10.3393/ac.2019.03.03. Epub 2020 Feb 18.
6
Age and Lymph Node Positivity in Patients With Colon and Rectal Cancer in the US Military Health System.美国军事医疗体系中结直肠癌患者的年龄与淋巴结阳性率。
Dis Colon Rectum. 2020 Mar;63(3):346-356. doi: 10.1097/DCR.0000000000001555.
7
Impact of Age on Risk of Lymph Node Positivity in Patients with Colon Cancer.年龄对结肠癌患者淋巴结阳性风险的影响
J Cancer. 2019 May 12;10(9):2102-2108. doi: 10.7150/jca.28377. eCollection 2019.
8
Reconsideration of the optimal minimum lymph node count for young colon cancer patients: a population-based study.重新考虑年轻结肠癌患者的最佳最小淋巴结计数:一项基于人群的研究。
BMC Cancer. 2018 Jun 1;18(1):623. doi: 10.1186/s12885-018-4428-0.
9
Outcome of young patients with rectal adenocarcinoma.年轻直肠腺癌患者的预后
J Gastrointest Oncol. 2017 Feb;8(1):96-101. doi: 10.21037/jgo.2016.09.04.
10
Chemotherapy Use and Survival Among Young and Middle-Aged Patients With Colon Cancer.年轻及中年结肠癌患者的化疗使用情况与生存率
JAMA Surg. 2017 May 1;152(5):452-459. doi: 10.1001/jamasurg.2016.5050.
J Natl Cancer Inst. 2005 Feb 2;97(3):219-25. doi: 10.1093/jnci/dji020.
4
Bevacizumab plus irinotecan, fluorouracil, and leucovorin for metastatic colorectal cancer.贝伐单抗联合伊立替康、氟尿嘧啶和亚叶酸钙治疗转移性结直肠癌。
N Engl J Med. 2004 Jun 3;350(23):2335-42. doi: 10.1056/NEJMoa032691.
5
FOLFIRI followed by FOLFOX6 or the reverse sequence in advanced colorectal cancer: a randomized GERCOR study.晚期结直肠癌中FOLFIRI序贯FOLFOX6或相反顺序:一项GERCOR随机研究
J Clin Oncol. 2004 Jan 15;22(2):229-37. doi: 10.1200/JCO.2004.05.113. Epub 2003 Dec 2.
6
Rates of colon and rectal cancers are increasing in young adults.年轻成年人中结肠癌和直肠癌的发病率正在上升。
Am Surg. 2003 Oct;69(10):866-72.
7
Influence of obesity on lymph node recovery from rectal resection specimens.肥胖对直肠切除标本淋巴结恢复的影响。
Pathol Oncol Res. 2003;9(3):180-3. doi: 10.1007/BF03033734. Epub 2003 Oct 7.
8
Colon cancer survival is associated with increasing number of lymph nodes analyzed: a secondary survey of intergroup trial INT-0089.结肠癌生存率与所分析淋巴结数量的增加相关:对组间试验INT - 0089的二次调查
J Clin Oncol. 2003 Aug 1;21(15):2912-9. doi: 10.1200/JCO.2003.05.062.
9
Favorable influence of age on tumor characteristics of sporadic colorectal adenocarcinoma: patients 30 years of age or younger may be a distinct patient group.年龄对散发性结直肠癌肿瘤特征的有利影响:30岁及以下的患者可能是一个独特的患者群体。
Dis Colon Rectum. 2003 Jul;46(7):904-10. doi: 10.1007/s10350-004-6683-1.
10
Clinicopathological and molecular biological features of colorectal cancer in patients less than 40 years of age.40岁以下结直肠癌患者的临床病理及分子生物学特征
Br J Surg. 2003 Feb;90(2):205-14. doi: 10.1002/bjs.4015.